Medtronic MDT Diabetes — Currency translation and other
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's diabetes — currency translation and other.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medtronic's diabetes — currency translation and other?
- Medtronic (MDT) reported diabetes — currency translation and other of $0 in Q4 2025.
- What is the long-term trend for Medtronic's diabetes — currency translation and other?
- Over 3 years (2022 to 2025), Medtronic's diabetes — currency translation and other has grown at a 0.0% compound annual growth rate (CAGR), from -$1M to $1M.
- What does diabetes — currency translation and other mean?
- The financial impact of changing currency exchange rates and other minor non-operational items on the diabetes segment.
- How do you interpret diabetes — currency translation and other?
- A negative value indicates a headwind from currency fluctuations, while a positive value indicates a tailwind.
- How does diabetes — currency translation and other compare across companies?
- Standard adjustment line item for multinational companies reporting segment performance.